[go: up one dir, main page]

WO2009011112A1 - Émulsion de graisse stable contenant de la prostaglandine e1 - Google Patents

Émulsion de graisse stable contenant de la prostaglandine e1 Download PDF

Info

Publication number
WO2009011112A1
WO2009011112A1 PCT/JP2008/001865 JP2008001865W WO2009011112A1 WO 2009011112 A1 WO2009011112 A1 WO 2009011112A1 JP 2008001865 W JP2008001865 W JP 2008001865W WO 2009011112 A1 WO2009011112 A1 WO 2009011112A1
Authority
WO
WIPO (PCT)
Prior art keywords
fat emulsion
emulsion containing
prostaglandin
containing prostaglandin
stable fat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/001865
Other languages
English (en)
Japanese (ja)
Inventor
Takayuki Fukuyama
Kazuhiko Ozaki
Kenichi Hirai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Taisho Pharmaceutical Co Ltd
Original Assignee
Mitsubishi Tanabe Pharma Corp
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp, Taisho Pharmaceutical Co Ltd filed Critical Mitsubishi Tanabe Pharma Corp
Priority to JP2009523535A priority Critical patent/JP5890599B2/ja
Priority to KR1020157002118A priority patent/KR101588558B1/ko
Priority to CN200880024114A priority patent/CN101743010A/zh
Publication of WO2009011112A1 publication Critical patent/WO2009011112A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'invention porte sur une émulsion de graisse contenant un composé ayant une activité de prostaglandine E1, laquelle émulsion de graisse est scellée hermétiquement dans un conteneur en verre puis thermostérilisée. La quantité résiduelle de l'activité de prostaglandine E1 après un stockage de 16 mois à 5 °C n'est pas inférieure à 65 % mais non supérieure à 100 % de l'activité de prostaglandine E1 au commencement du stockage.
PCT/JP2008/001865 2007-07-13 2008-07-11 Émulsion de graisse stable contenant de la prostaglandine e1 Ceased WO2009011112A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2009523535A JP5890599B2 (ja) 2007-07-13 2008-07-11 プロスタグランジンｅ１を含む安定な脂肪乳剤
KR1020157002118A KR101588558B1 (ko) 2007-07-13 2008-07-11 프로스타글란딘 ｅ１을 포함하는 안정한 지방 유제
CN200880024114A CN101743010A (zh) 2007-07-13 2008-07-11 含有前列腺素e1的稳定的脂肪乳剂

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-184358 2007-07-13
JP2007184358 2007-07-13

Publications (1)

Publication Number Publication Date
WO2009011112A1 true WO2009011112A1 (fr) 2009-01-22

Family

ID=40259458

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/001865 Ceased WO2009011112A1 (fr) 2007-07-13 2008-07-11 Émulsion de graisse stable contenant de la prostaglandine e1

Country Status (6)

Country Link
JP (2) JP5890599B2 (fr)
KR (2) KR101588558B1 (fr)
CN (1) CN101743010A (fr)
MY (1) MY158088A (fr)
TW (1) TW200920379A (fr)
WO (1) WO2009011112A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013006811A (ja) * 2011-06-27 2013-01-10 Fujifilm Corp 容器詰製剤
WO2019230964A1 (fr) * 2018-05-31 2019-12-05 富士フイルム株式会社 Composition d'émulsion de type huile dans eau conditionnée

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102038639B (zh) * 2010-12-24 2012-05-02 海南碧凯药业有限公司 一种前列地尔注射制剂
CN102198095A (zh) * 2011-05-03 2011-09-28 北京中海康医药科技发展有限公司 一种依前列醇脂肪乳及其制备方法
CN107519132A (zh) * 2017-08-29 2017-12-29 辅必成（上海）医药科技有限公司 一种前列地尔的纳米脂肪乳剂

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02175630A (ja) * 1988-12-27 1990-07-06 Matsumoto Seiyaku Kogyo Kk 医療用ガラス製品内表面の金属酸化物処理によるアルカリ等の溶出防止法
JPH06263481A (ja) * 1992-11-18 1994-09-20 Koa Glass Kk アルカリ等の溶出防止機能を有するガラス製品及びその製造方法
JPH0769897A (ja) * 1993-09-01 1995-03-14 Green Cross Corp:The 血中トリグリセリド低下作用剤
JPH09235230A (ja) * 1995-12-29 1997-09-09 Hisamitsu Pharmaceut Co Inc イオントフォレーシス用製剤
WO1999009992A1 (fr) * 1997-08-27 1999-03-04 Yoshitomi Pharmaceutical Industries, Ltd. Promoteurs de neovascularisation
JP2006188474A (ja) * 2005-01-07 2006-07-20 Nichi-Iko Pharmaceutical Co Ltd 安定性に優れた脂肪乳剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07206472A (ja) * 1994-01-12 1995-08-08 Nippon Electric Glass Co Ltd 医薬用ホウケイ酸ガラス
JPH08104620A (ja) * 1994-10-05 1996-04-23 Green Cross Corp:The 薬物含有脂肪乳剤
JPH08175998A (ja) * 1994-12-19 1996-07-09 Takada Seiyaku Kk シリコート容器を用いた凍結乾燥製剤
JP2001328612A (ja) * 2000-05-22 2001-11-27 Daiwa Tokushu Glass Kk 低アルカリガラス容器及びその製造方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02175630A (ja) * 1988-12-27 1990-07-06 Matsumoto Seiyaku Kogyo Kk 医療用ガラス製品内表面の金属酸化物処理によるアルカリ等の溶出防止法
JPH06263481A (ja) * 1992-11-18 1994-09-20 Koa Glass Kk アルカリ等の溶出防止機能を有するガラス製品及びその製造方法
JPH0769897A (ja) * 1993-09-01 1995-03-14 Green Cross Corp:The 血中トリグリセリド低下作用剤
JPH09235230A (ja) * 1995-12-29 1997-09-09 Hisamitsu Pharmaceut Co Inc イオントフォレーシス用製剤
WO1999009992A1 (fr) * 1997-08-27 1999-03-04 Yoshitomi Pharmaceutical Industries, Ltd. Promoteurs de neovascularisation
JP2006188474A (ja) * 2005-01-07 2006-07-20 Nichi-Iko Pharmaceutical Co Ltd 安定性に優れた脂肪乳剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TEAGARDEN D.L. ET AL.: "Dehydration Kinetics of Prostaglandin E1 in a lipid Emulsion", PHARMACEUTICAL RESEARCH, vol. 6, no. 3, 1989, pages 210 - 215, XP000942335 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013006811A (ja) * 2011-06-27 2013-01-10 Fujifilm Corp 容器詰製剤
WO2019230964A1 (fr) * 2018-05-31 2019-12-05 富士フイルム株式会社 Composition d'émulsion de type huile dans eau conditionnée

Also Published As

Publication number Publication date
KR101588558B1 (ko) 2016-01-28
JP5965944B2 (ja) 2016-08-10
TW200920379A (en) 2009-05-16
KR20100053541A (ko) 2010-05-20
JPWO2009011112A1 (ja) 2010-09-16
CN101743010A (zh) 2010-06-16
KR20150017775A (ko) 2015-02-17
JP5890599B2 (ja) 2016-03-22
MY158088A (en) 2016-08-30
JP2014224131A (ja) 2014-12-04

Similar Documents

Publication Publication Date Title
WO2009091717A3 (fr) Tabac sans fumée
WO2011159839A3 (fr) Composés de thioacétate, compositions et procédés d'utilisation
WO2009011112A1 (fr) Émulsion de graisse stable contenant de la prostaglandine e1
MX2011012122A (es) Derivados de tiofeno.
WO2006078659A8 (fr) Compositions stables contenant de la prostaglandine
WO2007144770A3 (fr) Bactérie
WO2012129161A3 (fr) Solutions stabilisées d'acide hypohalogéneux
WO2011159840A3 (fr) Phénylthioacétates, compositions et procédés d'application
WO2009020067A1 (fr) Préparation cosmétique liquide
GB201021827D0 (en) Flavour stick
EA200801859A1 (ru) Неводная композиция стабильного витамина "c", способ ее приготовления и применения
GEP20146015B (en) Novel acetylsalicylic acid salts
WO2008136393A1 (fr) Cristaux de composé lactame et leur procédé de fabrication
GB0514463D0 (en) Use of pinolenic acid
NZ606366A (en) Stabilization of fsh
WO2011143785A8 (fr) Récipient en verre scellé présentant un piston coulissant
WO2011162523A3 (fr) Composition pour prévenir ou traiter l'ostéoporose, contenant du ssangwhatang ou un produit fermenté par lactobacillus de celui-ci
WO2007050684A3 (fr) Compositions de fluorure-calcium, produits dentaires et procedes d'apport de fluorure dentaire
PE20151426A1 (es) Solucion para preservar conductos vasculares
MX356093B (es) Un empaque que contiene un condón.
WO2010025859A3 (fr) Stabilisation de cellules au moyen de liquides ioniques
WO2008099835A1 (fr) Bande de soudage pour capsules dures contenant du peg encapsulé
PH12012501281B1 (en) Flavor-improving material
WO2007104760A3 (fr) Lyophilisat de plasma
MX2007004881A (es) Ingredientes alimenticios bioactivos protectores utilizando microorganismos que tienen capacidad metabolizante reducida.

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880024114.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08776824

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 12010500027

Country of ref document: PH

ENP Entry into the national phase

Ref document number: 2009523535

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20107002368

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 763/CHENP/2010

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: PI 20095677

Country of ref document: MY

122 Ep: pct application non-entry in european phase

Ref document number: 08776824

Country of ref document: EP

Kind code of ref document: A1